13-Mar-2026
DaVita tops chart as the only large-cap healthcare services name rated Strong Buy
Seeking Alpha News (Mon, 9-Mar 11:24 AM ET)
AM Best Affirms Credit Ratings of The Cigna Group and Its Subsidiaries
Business Wire (Wed, 4-Mar 5:40 PM ET)
PRNewswire (Tue, 3-Mar 7:30 AM ET)
The Cigna Group Announces Appearance at the TD Cowen 46th Annual Health Care Conference
PRNewswire (Mon, 2-Mar 6:00 AM ET)
PRNewswire (Thu, 12-Feb 9:00 AM ET)
PRNewswire (Thu, 5-Feb 6:00 AM ET)
Broad Corporate Collaboration Fuels Student Wellness and Opportunity at Super Bowl Week Event
Market Chameleon (Wed, 4-Feb 4:42 AM ET)
PRNewswire (Tue, 3-Feb 8:17 PM ET)
PRNewswire (Tue, 3-Feb 11:00 AM ET)
PRNewswire (Thu, 15-Jan 9:00 AM ET)
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Cigna Group trades on the NYSE stock market under the symbol CI.
As of March 13, 2026, CI stock price climbed to $267.19 with 1,201,346 million shares trading.
CI has a beta of 0.14, meaning it tends to be less sensitive to market movements. CI has a correlation of 0.01 to the broad based SPY ETF.
CI has a market cap of $71.31 billion. This is considered a Large Cap stock.
Last quarter Cigna Group reported $72 billion in Revenue and $8.08 earnings per share. This beat revenue expectation by $3 billion and exceeded earnings estimates by $.20.
In the last 3 years, CI traded as high as $370.83 and as low as $239.51.
The top ETF exchange traded funds that CI belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
CI has underperformed the market in the last year with a price return of -12.4% while the SPY ETF gained +21.4%. However, in the short term, CI had mixed performance relative to the market. It has outperformed in the last 3 months, returning -2.2% vs -2.6% return in SPY. But in the last 2 weeks, CI shares have been beat by the market, returning -7.3% compared to an SPY return of -3.5%.
CI support price is $261.13 and resistance is $270.63 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CI shares will trade within this expected range on the day.